Cardiac Rhythm and Affecting Factors in Patients Hospitalized in the Physical Therapy and Rehabilitation Clinic

June 7, 2022 updated by: Hande Ozdemir, Trakya University
In our study, it is aimed to evaluate the cardiac rhythms of patients who are decided to receive inpatient treatment in the physical therapy and rehabilitation clinic due to any neuromusculoskeletal diseases with 24 hour rhythm holter follow up on the day of hospitalization and three weeks after hospitalization and to determine the factors that may affect this result if a significant change is observed between the two measurements.The present results will guide the determination of the exercise duration, intensity, type and severity of the exercises to be created within the scope of the treatment programs of the patients and will lead to similar studies.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Neuromusculoskeletal disorders include a variety of fairly common pathologies that can have a major impact on a person's health. Today, neuromusculoskeletal diseases are the main causes of occupational diseases and chronic physical disability leading to high health care costs globally. Exercise therapy is seen as an important part of the treatment of many neuromusculoskeletal diseases.

Patients hospitalized in the physical therapy and rehabilitation clinic are generally elderly people with chronic neuromusculoskeletal system disorders. While the presence of ventricular premature beat is detected in more than 50% of healthy adults in 24 hour rhythm holter examination, this rate rises above 90% in the elderly.Although many studies have noted that regular exercise and high cardiovascular fitness reduce the risk of cardiovascular arrhythmias, exercise may paradoxically increase the risk of sudden cardiac death in those with preexisting cardiac abnormalities.

There are no studies evaluating the changes in heart rhythms during hospitalization of patients hospitalized for treatment in physical therapy and rehabilitation clinics where exercise therapy is frequently applied.In our study, it is aimed to evaluate the cardiac rhythms of patients who receive inpatient treatment in the physical therapy and rehabilitation clinic with 24 hour rhythm holter follow up on the day of hospitalization and three weeks after hospitalization and to determine the factors that may affect this result if a significant change is observed between the two measurements.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Edirne, Turkey, 22030
        • Trakya University Medical Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients hospitalized in Trakya University Hospital Physiotherapy and Rehabilitation Clinic

Description

Inclusion Criteria:

  • Be over 18 years old
  • To be evaluated for any neuromusculoskeletal system disease and decided to be treated as an inpatient in the physical therapy and rehabilitation clinic
  • Having agreed to participate in the study

Exclusion Criteria:

  • A change in medication that may affect cardiac rhythm in the last two weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evalution of the cardiac arrhythmia
Time Frame: up to three weeks
24-hour cardiac rhythm recording by holter device
up to three weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Trakya University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 29, 2021

Primary Completion (Anticipated)

December 28, 2022

Study Completion (Anticipated)

December 28, 2022

Study Registration Dates

First Submitted

May 16, 2022

First Submitted That Met QC Criteria

May 18, 2022

First Posted (Actual)

May 19, 2022

Study Record Updates

Last Update Posted (Actual)

June 10, 2022

Last Update Submitted That Met QC Criteria

June 7, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2021/161

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurumusculoskeletal Disorders

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe